Magnesium supplementation and preeclampsia in low-income pregnant women - a randomized double-blind clinical trial.

ABSTRACT:

Background

Preeclampsia is the major cause of maternal morbidity and mortality in developing countries. Magnesium sulfate is considered first-line therapy against eclampsia and magnesium deficiency in pregnancy has been associated with unfavourable perinatal outcomes. However there are doubts if magnesium supplementation during pregnancy can previne preeclampsia especially in population with high nutritional risk. This trial aims to verify the effect of oral magnesium supplmentation on preeclampsia incidence in low income pregnant women.

Methods

This randomized, double-blind, placebo-controlled trial investigated the effect of oral magnesium citrate supplementation for preeclampsia in low-income Brazilian pregnant women, i.e. annual per capita income of US$ 1025 or less. Par

SUBMITTER: de Araujo CAL 

PROVIDER: S-EPMC7146998 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature